ICE processing and kinetic mechanism

Journal of Cellular Biochemistry

Volumn 64, Issue 1, 1997, Pages 11-18

  Giegel, David A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME;

ARTICLE; CATALYSIS; COVALENT BOND; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ACYLATION; BINDING SITES; CASPASE 1; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; HYDROXYLAMINE; HYDROXYLAMINES; KINETICS; MODELS, BIOLOGICAL; PAPAIN; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EID: 0031052944     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199701)64:1<11::AID-JCB3>3.0.CO;2-2     Document Type: Article

References (35)

1. Ayala JM, Yamin TT, Egger LA, Chin J, Kostura MJ, Miller DK (1994): IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol 153:2592-2599.
2. Baker D, Silen JL, Agard DA (1992a): Protease pro region required for folding is a potent inhibitor of the mature enzyme. Proteins 12:339-344.
3. Baker D, Sohl JL, Agard DA (1992b): A protein-folding reaction under kinetic control. Nature 356:263-265.
4. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K (1982): L-trans-Epoxysuccinylleucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201:189-198.
5. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP (1988): Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437-9442.
6. Black RA, Kronheim SR, Sleath PR (1989): Activation of interleukin-1 beta by a co-induced protease. FEBS Lett 247:386-390.
7. Buras JA, Monks BG, Fenton MJ (1994): The NF-beta A-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1 beta gene expression. J Immunol 152:4444-4454.
8. Capdevila JH, Morrow JD, Belosludtsev YY, Beauchamp DR, DuBois RN, Falck JR (1995): The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry 34:3325-3337.
9. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van-Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA (1992): Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97-100.
10. Chin J, Kostura MJ (1993): Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J Immunol 151:5574-5585.
11. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W-W, Dixit VM (1996): ICE-LAP-3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 Is activated during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem, 271:1621-1625.
12. Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Herve F, Collard Dutilleul V, Gu Y, Aldape RA, Lippke JA (1995): A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 14:1914-1922.
13. Fernandes-Alnemri T, Litwack G, Alnemri ES (1995): Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 55:2737-2742.
14. Godambe SA, Chaplin DD, Takova T, Bellone CJ (1994): Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1 beta gene. J Immunol 153:143-152.
15. Gray CJ, Boukouvalas J, Szawelski RJ, Wharton CW (1984): Benzyloxycarbonylphenylalanylcitrulline p-nitroanilide as a substrate for papain and other plant cysteine proteinases. Biochem J 219:325-328.
16. Gu Y, Wu J, Faucheu C, Lalanne JL, Diu A, Livingston DJ, Su MS (1995): Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 14:1923-1931.
17. Herzyk DJ, Allen JN, Marsh CB, Wewers MD (1992): Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. J Immunol 149:3052-3058.
18. Hinkle PM, Kirsch JF (1971): Demonstration of a change in the rate-determining step in papain- and ficin-catalyzed acyl-transfer reactions. Biochemistry 10:2717-2726.
19. Howard AD, Kostura MJ, Thornberry N, Ding GJ, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA (1991): IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol 147:2964-2969.
20. Jia Z, Hasnain S, Hirama T, Lee X, Mort JS, To R, Huber CP (1995): Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. J Biol Chem 270:5527-5533.
21. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P (1995): Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 270: 15250-15256.
22. Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G (1994): Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 269:19331-19337.
23. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA (1989): Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 86:5227-5231.
24. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux SM, Yamin TT, Yu VL, Nicholson DW (1995): Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 270:15870-15876.
25. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA (1995): Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
26. Ramage P, Cheneval D, Chevi M, Graff P, Hemmig R, Heng R, Kocher HP, Mackenzie A, Memmert K, Revesz L (1995). Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 270:9378-9383.
27. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ (1992): Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69:597-604.
28. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T (1994): Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 269:11769-11775.
29. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T-T, Nicholson DW (1996): CPP32/Apopain is a key interleukin-1β converting enzyme-like protease involved in fas-mediated apoptosis. J Biol Chem 271:1841-1844.
30. Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, Miller DK, Chapman K, Kostura MJ (1995): The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immunoelectron microscopy. J Exp Med 182:1447-1459.
31. Sleath PR, Hendrickson RC, Kronheim SR, March CJ, Black RA (1990): Substrate specificity of the protease that processes human interleukin-1 beta. J Biol Chem 265:14526-14528.
32. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J (1992): A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-774.
33. Vannier E, Miller LC, Dinarello CA (1992): Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 89:4076-4080.
34. Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD (1994): Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: A (p20/p10)2 homodimer. Cell 78:343-352.
35. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA (1994): Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370:270-275.